# A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers

> **NCT03936166** · PHASE1 · COMPLETED · sponsor: **Crinetics Pharmaceuticals Inc.** · enrollment: 57 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CRN01941 Oral Solution
- **DRUG:** CRN01941 Oral Capsule
- **DRUG:** Placebo Oral Solution
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT03936166
- **Lead sponsor:** Crinetics Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-29
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936166, "A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03936166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*